B. J. Goldstein

2.8k total citations
46 papers, 2.3k citations indexed

About

B. J. Goldstein is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, B. J. Goldstein has authored 46 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 27 papers in Endocrinology, Diabetes and Metabolism and 10 papers in Surgery. Recurrent topics in B. J. Goldstein's work include Diabetes Treatment and Management (23 papers), Metabolism, Diabetes, and Cancer (21 papers) and Protein Tyrosine Phosphatases (12 papers). B. J. Goldstein is often cited by papers focused on Diabetes Treatment and Management (23 papers), Metabolism, Diabetes, and Cancer (21 papers) and Protein Tyrosine Phosphatases (12 papers). B. J. Goldstein collaborates with scholars based in United States, Canada and Sweden. B. J. Goldstein's co-authors include Faiyaz Ahmad, Keith D. Kaufman, Debora Williams‐Herman, Serge Jabbour, Naotake Hashimoto, Gregory T. Golm, Ronald Cortright, G. Lynis Dohm, J. L. Azevedo and Robert V. Considine and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and The Journal of Immunology.

In The Last Decade

B. J. Goldstein

45 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. J. Goldstein United States 26 1.3k 1.2k 488 396 291 46 2.3k
Anselm T. Bäumer Germany 18 656 0.5× 772 0.6× 768 1.6× 312 0.8× 152 0.5× 29 2.7k
Anne Minnich United States 20 1.1k 0.8× 433 0.4× 834 1.7× 212 0.5× 207 0.7× 34 2.1k
J.C. Fruchart France 21 1.4k 1.1× 741 0.6× 934 1.9× 149 0.4× 255 0.9× 60 2.6k
Uday Saxena United States 26 649 0.5× 698 0.6× 542 1.1× 300 0.8× 95 0.3× 54 2.1k
Ernst U. Frevert United States 16 1.2k 0.9× 408 0.3× 521 1.1× 163 0.4× 154 0.5× 24 1.7k
Bradley A. Zinker United States 18 1.2k 0.9× 447 0.4× 470 1.0× 191 0.5× 122 0.4× 41 1.9k
Cyrille Maugeais United States 30 829 0.6× 1.3k 1.1× 1.3k 2.8× 169 0.4× 238 0.8× 54 2.8k
C L Bisgaier United States 25 906 0.7× 1.1k 0.9× 1.3k 2.7× 135 0.3× 196 0.7× 37 3.2k
Masakazu Sakai Japan 24 677 0.5× 392 0.3× 736 1.5× 615 1.6× 165 0.6× 50 1.9k
Patrick I. Eacho United States 28 1.3k 1.0× 519 0.4× 1.1k 2.2× 179 0.5× 567 1.9× 61 2.7k

Countries citing papers authored by B. J. Goldstein

Since Specialization
Citations

This map shows the geographic impact of B. J. Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. J. Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. J. Goldstein more than expected).

Fields of papers citing papers by B. J. Goldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. J. Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. J. Goldstein. The network helps show where B. J. Goldstein may publish in the future.

Co-authorship network of co-authors of B. J. Goldstein

This figure shows the co-authorship network connecting the top 25 collaborators of B. J. Goldstein. A scholar is included among the top collaborators of B. J. Goldstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. J. Goldstein. B. J. Goldstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Reasner, Charles A., Leann Olansky, Thomas Seck, et al.. (2011). The effect of initial therapy with the fixed‐dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 13(7). 644–652. 75 indexed citations
2.
Seck, Thomas, Lei Xu, Christine McCrary Sisk, et al.. (2011). Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin vs. pioglitazone in drug-naïve patients with type 2 diabetes. International Journal of Clinical Practice. 65(9). 930–938. 35 indexed citations
3.
Wainstein, Julio, Leonid Katz, Samuel S. Engel, et al.. (2011). Initial therapy with the fixed‐dose combination of sitagliptin and metformin results in greater improvement in glycaemic control compared with pioglitazone monotherapy in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 14(5). 409–418. 40 indexed citations
4.
5.
6.
Engel, Samuel S., Debora Williams‐Herman, Gregory T. Golm, et al.. (2010). Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis. International Journal of Clinical Practice. 64(7). 984–990. 111 indexed citations
7.
Aschner, Pablo, H. L. Katzeff, Hongquan Guo, et al.. (2009). Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 12(3). 252–261. 135 indexed citations
8.
Goldstein, B. J., et al.. (2008). Modulating an oxidative-inflammatory cascade: potential new treatment strategy for improving glucose metabolism, insulin resistance, and vascular function. International Journal of Clinical Practice. 62(7). 1087–1095. 127 indexed citations
9.
Goldstein, B. J., et al.. (2007). Type 2 diabetes - treat early, treat intensively. International Journal of Clinical Practice. 61(157). 16–21. 15 indexed citations
10.
Goldstein, B. J.. (2006). Closing the gap between clinical research and clinical practice: can outcome studies with thiazolidinediones improve our understanding of type 2 diabetes?. International Journal of Clinical Practice. 60(7). 873–883. 1 indexed citations
11.
Rosenstock, Julio, B. J. Goldstein, A Vinik, et al.. (2005). Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (>60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study. Diabetes Obesity and Metabolism. 8(1). 49–57. 52 indexed citations
12.
Jovanovič, Lois, et al.. (2000). Repaglinide in Type 2 Diabetes: A 24-Week, Fixed-Dose Efficacy and Safety Study. The Journal of Clinical Pharmacology. 40(1). 49–57. 64 indexed citations
13.
Kole, Hemanta K., et al.. (1998). Inhibition of the Transmembrane Protein Tyrosine Phosphatase LAR by 3S-Peptide-I Enhances Insulin Receptor Phosphorylation in Intact Cells. Journal of Basic and Clinical Physiology and Pharmacology. 9(2-4). 111–126. 1 indexed citations
14.
Ahmad, Faiyaz, J. L. Azevedo, Ronald Cortright, G. Lynis Dohm, & B. J. Goldstein. (1997). Alterations in skeletal muscle protein-tyrosine phosphatase activity and expression in insulin-resistant human obesity and diabetes.. Journal of Clinical Investigation. 100(2). 449–458. 243 indexed citations
15.
Wofsy, Carla, Chikako Torigoe, Ute M. Kent, H Metzger, & B. J. Goldstein. (1997). Exploiting the difference between intrinsic and extrinsic kinases: implications for regulation of signaling by immunoreceptors. The Journal of Immunology. 159(12). 5984–5992. 41 indexed citations
16.
Goldstein, B. J., et al.. (1996). Modulation of insulin signal transduction by eutopic overexpression of the receptor-type protein-tyrosine phosphatase LAR.. Molecular Endocrinology. 10(5). 575–584. 65 indexed citations
17.
Ahmad, Faiyaz, Robert V. Considine, & B. J. Goldstein. (1995). Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.. Journal of Clinical Investigation. 95(6). 2806–2812. 110 indexed citations
18.
Ding, Wei, et al.. (1994). Identification of Protein-Tyrosine Phosphatases Prevalent in Adipocytes by Molecular Cloning. Biochemical and Biophysical Research Communications. 202(2). 902–907. 20 indexed citations
19.
20.
Kwok, Ching‐Fai, et al.. (1989). Identification of persistent defects in insulin receptor structure and function capillary endothelial cells from diabetic rats.. Journal of Clinical Investigation. 83(1). 127–136. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anselm T. Bäumer Breakdown of academic impact, for papers by Anne Minnich Breakdown of academic impact, for papers by J.C. Fruchart Breakdown of academic impact, for papers by Uday Saxena Breakdown of academic impact, for papers by Ernst U. Frevert Breakdown of academic impact, for papers by Bradley A. Zinker Breakdown of academic impact, for papers by Cyrille Maugeais Breakdown of academic impact, for papers by C L Bisgaier Breakdown of academic impact, for papers by Masakazu Sakai Breakdown of academic impact, for papers by Patrick I. Eacho
Rankless by CCL
2026